| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |